Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 67751 

Docket: For access to the docket to 

read background documents or 

comments received, go to https://

www.regulations.gov and search for 

‘‘EEOC–2023–0005’’ or ‘‘RIN 3046– 

ZA02.’’ The received comments also 

will be available for review at the 

Commission’s library, 131 M Street NE, 

Suite 4NW08R, Washington, DC 20507, 

between the hours of 9:30 a.m. and 5:00 

p.m., from November 1, 2023 until the 

Commission publishes the guidance in 

final form. You must make an 

appointment with library staff to review 

the comments in the Commission’s 

library. 

FOR FURTHER INFORMATION CONTACT: 

Lynn Davenport, Assistant Legal 

Counsel, lynn.davenport@eeoc.gov; 

Office of Legal Counsel, 202–856–7072 

(voice), 1–800–669–6820 (TTY). 

SUPPLEMENTARY INFORMATION: 

Background 

The EEOC is seeking public 

comments on all aspects of its proposed 

‘‘Enforcement Guidance on Harassment 

in the Workplace’’ (proposed guidance) 

pursuant to 29 CFR part 1695. The 

proposed guidance presents a legal 

analysis of standards for harassment and 

employer liability applicable to claims 

of harassment under the equal 

employment opportunity statutes 

enforced by the Commission. The 

Commission posted and requested 

public input on a proposed guidance on 

workplace harassment in January 2017, 

which was not finalized. 

The contents of the final guidance 

document will not have the force and 

effect of law and are not meant to bind 

the public in any way. The document is 

intended only to provide clarity to the 

public regarding Commission policies 

and existing requirements under the 

law. The standards discussed under 

EEOC-enforced laws will not necessarily 

apply to allegations of unlawful 

harassment under other Federal laws or 

under State or local laws. 

For the Commission: 

Charlotte A. Burrows, 

Chair. 

[FR Doc. 2023–21644 Filed 9–29–23; 8:45 am] 

BILLING CODE 6570–01–P 

FARM CREDIT SYSTEM INSURANCE 

CORPORATION 

Board of Directors Meeting 

SUMMARY: Notice of the forthcoming 

regular meeting of the Board of Directors 

of the Farm Credit System Insurance 

Corporation (FCSIC), is hereby given in 

accordance with the provisions of the 

Bylaws of the FCSIC. 

DATES: 10 a.m., Wednesday, October 11, 

2023. 

ADDRESSES: You may observe the open 

portions of this meeting in person at 

1501 Farm Credit Drive, McLean, 

Virginia 22102–5090, or virtually. If you 

would like to virtually attend, at least 24 

hours in advance, visit FCSIC.gov, select 

‘‘News & Events,’’ then select ‘‘Board 

Meetings.’’ From there, access the 

linked ‘‘Instructions for board meeting 

visitors’’ and complete the described 

registration process. 

FOR FURTHER INFORMATION CONTACT: If 

you need more information or assistance 

for accessibility reasons, or have 

questions, contact Ashley Waldron, 

Secretary to the Board. Telephone: 703– 

883–4009. TTY: 703–883–4056. 

SUPPLEMENTARY INFORMATION: Parts of 

this meeting will be open to the public. 

The rest of the meeting will be closed 

to the public. The following matters will 

be considered: 

Portions Open to the Public 

• Approval of Minutes for July 12, 2023 

• Quarterly FCSIC Financial Reports 

• Quarterly Report on Insured 

Obligations 

• Quarterly Report on Annual 

Performance Plan 

• Annual Performance Plan 

• Budget 2024–2025 

Portions Closed to the Public 

• Confidential Report on Insurance Risk 

Ashley Waldron, 

Secretary to the Board. 

[FR Doc. 2023–21681 Filed 9–29–23; 8:45 am] 

BILLING CODE 6705–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y, (12 

CFR part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors, 

Ann E. Misback, Secretary of the Board, 

20th Street and Constitution Avenue 

NW, Washington DC 20551–0001, not 

later than October 17, 2023. 

A. Federal Reserve Bank of New York 

(Ivan J. Hurwitz, Head of Bank 

Applications) 33 Liberty Street, New 

York, New York 10045–0001. Comments 

can also be sent electronically to 

comments.applications@ny.frb.org: 

1. The Goldman Sachs Group, Inc., 

New York, New York; to engage in 

community development activities 

pursuant to section 225.28(b)(12) of the 

Board’s Regulation Y. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–21737 Filed 9–29–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Advisory 

Committee on Breast Cancer in Young 

Women (ACBCYW) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

ACBCYW. The ACBCYW consists of 15 

experts in fields associated with breast 

cancer, disease prevention, early 

detection, diagnosis, public health, 

social marketing, genetic screening and 

counseling, treatment, rehabilitation, 

palliative care, and survivorship in 


lotter on DSK11XQN23PROD with NOTICES1
67752 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 

young women, or in related disciplines 

with a specific focus on young women. 

DATES: Nominations for membership on 

the ACBCYW must be received no later 

than November 10, 2023. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

mailed to Kimberly E. Smith, MBA, 

MHA. c/o ACBCYW Secretariat, Centers 

for Disease Control and Prevention, 

3719 North Peachtree Road, Building 

100, Chamblee, Georgia 30341 or 

emailed (recommended) to acbcyw@

cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly E. Smith, MBA, MHA, 

Designated Federal Officer, National 

Center for Chronic Disease Prevention 

and Health Promotion, CDC, 4770 

Buford Highway NE, Mailstop S107–4, 

Atlanta, Georgia 30341, Telephone: 

(404) 498–0073; acbcyw@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the committee’s 

objectives. Nominees will be selected 

based on expertise in the fields of breast 

health, breast cancer, disease prevention 

and risk reduction, survivorship 

(including metastatic breast cancer), 

hereditary breast and ovarian cancer 

(HBOC), or in related disciplines with a 

specific focus on young women. Persons 

with personal experience with early 

onset breast cancer are also eligible to 

apply. This includes but may not be 

limited to breast cancer survivors <45 

years of age and caregivers of said 

persons. Federal employees will not be 

considered for membership. Members 

may be invited to serve up to four-year 

terms. Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of ACBCYW 

objectives (http://www.cdc.gov/maso/ 

facm/facmacbcyw.html). 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented, and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for ACBCYW membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in November 2024, 

or as soon as the HHS selection process 

is completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. SGE nominees must be 

U.S. citizens and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the following 

items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.). 

D A short biography (150 words or 

less). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–21568 Filed 9–29–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2023–0076] 

Advisory Committee on Immunization 

Practices (ACIP); Amended Notice of 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

Advisory Committee on Immunization 

Practices (ACIP). This meeting is open 

to the public. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, Committee 

Management Specialist, Advisory 

Committee on Immunization Practices, 

National Center for Immunization and 

Respiratory Diseases, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop H24–8, 

Atlanta, Georgia 30329–4027. 

Telephone: (404) 639–8836; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Advisory Committee on 

Immunization Practices (ACIP); 

September 22, 2023, 10 a.m. to 5 p.m., 

EDT (times subject to change, see the 

ACIP website for updates: https://

www.cdc.gov/vaccines/acip/index.

html), in the original Federal Register 

notice. 

Notice of the virtual meeting was 

published in the Federal Register on 

September 6, 2023, Volume 88, Number 

171, pages 60945–60946. 

Notice of the virtual meeting is being 

amended to add an additional agenda 

item in the matters to be considered, 

which should read as follows: 

Matters to be Considered: The agenda 

will include discussions of maternal 

respiratory syncytial virus (RSV) 

vaccine, child/adolescent immunization 

schedules and adult immunization 

schedule. A recommendation vote for 

maternal RSV vaccine is scheduled. A 

Vaccines for Children vote is scheduled 

for maternal RSV vaccine. Agenda items 

are subject to change as priorities 

dictate. For more information on the 

meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 


lotter on DSK11XQN23PROD with NOTICES1